Outcome of children exposed in utero to fluoxetine: A critical review

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 27-31

  Koren, Gideon ^a   Nulman, Irena ^a   Addis, Antonio ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

ADULT; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; INFANT; MOTHERS; PREGNANCY; SEROTONIN UPTAKE INHIBITORS;

EID: 0031757962     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<27::AID-DA5>3.0.CO;2-K     Document Type: Article

References (7)

1. Addis A, Koren G (1997) Safety of fluoxetine during the first trimester of pregnancy: Meta-analytical review of epidemiological data. Teratology 55:37-38.
2. Aron (1992) Better news on population. Lancet 339:1600.
3. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335:1010-1015.
4. Goldstein DI, Carbin LA, Sundell KL (1997) Effects of first trimester fluoxetine exposure on the newborn. Obstet Gynecol 89:713-718.
5. Nulman I, Rovet I, Stewart D et al. (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336:258-262.
6. Pastuszak A, Schick-Boschetto B, Zuber C et al. (1993) Pregnancy-outcome following first trimester exposure to fluoxetine (Prozac). JAMA 2693:2246-2248.
7. Shepard TM (1986) Catalog of Teratogenic Agents. Baltimore: Johns Hopkins University Press.